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Abstract 
We report on a polyethylenimine (PEI) covalently conjugated (α-NaYbF4:Tm3+)/CaF2 upconver-
sion nanoparticle (PEI-UCNP) and its use for labeling rat mesenchymal stem cells (rMSCs). The 
PEI-UCNPs absorb and emit near-infrared light, allowing for improved in vivo imaging depth over 
conventional probes. We found that such covalent surface conjugation by PEI results in a much 
more stable PEI-UCNP suspension in PBS compared to conventional electrostatic layer by layer 
(LbL) self-assembling coating approach. We systematically examined the effects of nanoparticle 
dose and exposure time on rat mesenchymal stem cell (rMSC) cytotoxicity. The exocytosis of 
PEI-UCNPs from labeled rMSCs and the impact of PEI-UCNP uptake on rMSC differentiation was 
also investigated. Our data show that incubation of 100-µg/mL PEI-UCNPs with rMSCs for 4 h led 
to efficient labeling of the MSCs, and such a level of PEI-UCNP exposure imposed little cytotoxicity 
to rMSCs (95% viability). However, extended incubation of PEI-UCNPs at the 100 µg/mL dose for 
24 hour resulted in some cytotoxicity to rMSCs (60% viability). PEI-UCNP labeled rMSCs also 
exhibited normal early proliferation, and the internalized PEI-UCNPs did not leak out to cause 
unintended labeling of adjacent cells during a 14-day transwell culture experiment. Finally, 
PEI-UCNP labeled rMSCs were able to undergo osteogenic and adipogenic differentiation upon in 
vitro induction, although the osteogenesis of labeled rMSCs appeared to be less potent than that of 
the unlabeled rMSCs. Taken together, PEI-UCNPs are promising agents for stem cell labeling and 
tracking. 
Key words: Near Infrared, Photoluminescence, Bioimaging, Upconversion Nanoparticles, Stem 
cell. 
Introduction 
Mesenchymal stem cells (MSCs) are multipotent 
cells that can differentiate into a number cell types. 
This technology holds great promise in a variety of 








[1], cardiovascular disease [2], spinal-cord injuries [3] 
and cancers [4]. In order to facilitate their therapeutic 
use, the migration and differentiation of transplanted 
stem cells must be monitored over time with high 
spatial resolution. Optical imaging has emerged as a 
promising method for cell labeling due to its high 
sensitivity, cost-effectiveness, and rapid processing 
time. However, typical labeling agents such as organic 
dyes and fluorescent nanoparticles emit visible light 
with limited tissue penetration depth. To this end, 
many near infrared (NIR) emitting probes have been 
developed that take advantage of the elevated light 
penetration depth of NIR light. However, current NIR 
probes have drawbacks for in vivo tracking of stem 
cells. For example, synthetic NIR dyes are rapidly 
photobleached, making them ill-suited for longitudi-
nal study of stem cell fate. Common NIR quantum 
dots (e.g., CdTe, InAs, PbS) are composed of highly 
toxic elements, limiting their clinical applications.  
Lanthanide-doped upconversion nanoparticles 
(UCNPs) are promising materials for stem cell track-
ing due to their unique optical properties. Unlike tra-
ditional organic- [5-7] and protein-based materials [8], 
metal complexes [9-12] or semiconductor quantum 
dots [13, 14], these UCNPs generally have converse 
excitation and emission profiles: they are excited at 
NIR (980 nm), which is converted to a higher energy 
for emission at a visible or a shorter NIR wavelength 
[15, 16]. We have recently developed a novel bio-
compatible (α-NaYbF4:Tm3+)/CaF2 UCNP with en-
hanced NIR emission [17]. We demonstrated that such 
core/shell UCNPs are ideal for high contrast and 
deep tissue bioimaging. For example, they are com-
pletely free of autofluorescence for in vitro cell imag-
ing and exhibit an exceptionally high sig-
nal-to-noise-ratio in vivo (i.e.,310 for Balb-c mice). The 
combination of NIR excitation and emission of this 
UCNP allows for outstanding tissue penetration 
depth (>3.2 cm), and it is 6-8 orders of magnitude 
brighter than conventional fluorescence based imag-
ing probes in two-photon processes [18-22], with 
minimal light scattering and background from the 
surrounding tissue [23-25]. In addition, this nanopar-
ticle is less toxic than quantum dots since they do not 
contain class I and class II toxic elements. The con-
stituent ions of the shell of this UCNP, calcium and 
fluoride, are essentially endogenous elements in the 
living systems.  
Proper surface modification of UCNPs is neces-
sary to facilitate cellular uptake and subsequent ap-
plications for stem cell labeling. The intrinsic dynamic 
nature of cell surface antigen presentations on MSCs 
and the lack of unique cell surface markers or marker 
combinations for some animal MSCs (particularly 
mouse MSCs) have made an antibody-based UCNP 
surface modification and MSC targeting approach 
elusive. Surface modification of UCNPs with poly-
cationic macromolecules enabling non-specific endo-
cytosis are facile and practical, and have been the 
most commonly used strategy for shuttling nanopar-
ticles across cell membranes for drug delivery or 
cell-labeling applications. Herein, we report on the 
development of a polyethylenimine (PEI)-conjugated 
(α-NaYbF4:Tm3+)/CaF2 UCNP. We evaluated its sta-
bility, cytotoxicity, cell uptake, exocytosis, and impact 
on cell proliferation and differentiation in regard to 
the labeling of rat mesenchymal stem cells (rMSCs).  
Materials and methods 
Materials 
Yb2O3 (99.9%), Tm2O3 (99.9%), CF3COONa 
(99.9%), CF3COOH, CaCO3, 1-octadecene (90%), oleic 
acid (90%), diethylene glycol (99%), 
1-Ethyl-3-(3-dimethylaminopropyl) carbodiimide 
hydrochloride (EDC⋅HCl), poly(acrylic acid) (PAA), 
N-hydroxysulfosuccinimide sodium salt (sulfo-NHS), 
NOBF4 (97%) and branched polyethylenimine (PEI, 
Mw 25,000) were all purchased from Sigma-Aldrich 
and used without further purification. The trifluoro-
acetates of Yb and Tm were prepared as described 
[26].  
Instrumentation 
The size and the morphology of the core and 
core/shell nanocrystals were characterized by trans-
mission electron microscopy (TEM) using a JEM-2010 
microscope at an acceleration voltage of 200 KV. The 
powder x-ray diffraction (XRD) patterns were rec-
orded by a Siemens D500 diffractometer using Cu Kα 
radiation (λ = 0.15418 nm). The 2θ angle of the XRD 
spectra was recorded at a scanning rate of 5 °/minute. 
Upconvertion photoluminescence (PL) spectra were 
recorded using a Fluorolog-3.11 Jobin Yvon spectro-
fluorimeter with a slit width defining a spectral reso-
lution of 2 nm. The PL was excited at 975 nm using a 
fiber-coupled laser diode (Sheaumann, MA, USA) 
introduced to the sample chamber of the spectrofluo-
rimeter. All upconversion PL spectra have been cor-
rected for the spectral sensitivity of the system. Pho-
tographic images of upconverting nanocrystal col-
loids were taken with a digital camera (Canon Pow-
ershot SD800IS, Japan) without any filters. 
Synthesis of PEI-Coated Core/Shell 
α-(NaYbF4:0.5% Tm3+)/CaF2 UCNPs  
The hydrophobic oleic acid coated 
α-(NaYbF4:0.5% Tm3+)/CaF2 UCNPs were fabricated 




based on our previously reported approach [17]. The 
PEI modification on the UCNPs was carried out in a 
3-step reaction (Scheme 1/Figure S1). In the first step, 
oleic acid ligands on the UCNP surface were removed 
using a nitrosonium tetrafluoroborate approach 
(NOBF4) [27]. During this reaction, 5 mL of oleic acid 
coated UCNP dispersion in hexane (∼5 mg/mL) was 
mixed with a 5 mL dichloromethane solution of 
NOBF4 (0.01 M) at room temperature. The resulting 
mixture was shaken gently, typically for 10 hours, 
until the precipitation of the UCNPs was observed. 
After centrifugation to remove the supernatant, the 
precipitated UCNPs were re-dispersed in dimethyl-
formamide (DMF). In order to purify the UCNPs, 
toluene and hexane (1:1 v/v) were added to flocculate 
the UCNP dispersion. After centrifugation, DMF was 
added to re-disperse the UCNPs, forming a stable 
colloidal dispersion. In the second step, 150 mg of 
PAA was added into a DMF dispersion of 
NOBF4-treated UCNPs (5 mL, ∼5 mg/mL) followed 
by vigorous stirring at 80 °C. After 30 minutes, the 
nanoparticles were precipitated by the addition of 
acetone and re-dispersed in water to form a stable 
dispersion. In the third step, the PAA-capped UCNPs 
were covalently grafted with branched PEI. 30 mg of 
PAA-capped UCNPs in 5 mL of DI water were acti-
vated by 1-Ethyl-3-(3-dimethylaminopropyl) car-
bodiimide hydrochloride (EDC⋅HCl, 50 mg) and sul-
fo-NHS (5 mg) in order to form the succinimidyl ester. 
PEI (20 mg) in PBS buffer (2 mL) was then added to 
the reaction. After 2 hours of incubation at room 
temperature, the PEI-conjugated UCNPs 
(PEI-UCNPs) were purified by centrifugation and 
re-dispersion in DI water (5 mL). The electrostatic 
layer-by-layer (LbL) self-assembled PEI coated 
UCNPs were synthesized as follows. PAA-capped 
UCNPs (30 mg) in 5 mL of DI water were mixed with 
PEI (20 mg) in a PBS buffer (2 mL). After 2 hours of 
incubation at room temperature, the PEI LbL assem-
bled UCNPs were purified by centrifugation and 
re-dispersion in DI water (5 mL). 
Isolation and culture of rat bone marrow 
stromal cells 
All animal procedures were conducted in ac-
cordance with the principles and procedures ap-
proved by the University of Massachusetts Medical 
School Animal Care and Use Committee. Rat bone 
marrow cells were isolated from the long bones of a 
4-week old male Charles River SASCO SD rat as pre-
viously described [28], and cultured in expansion 
media (ascorbic acid-free αMEM containing 20% FBS, 
2% L-Glutamine, and 1% Penicillin-Streptomycin) at 
37 ºC and 5% CO2. After removing non-adherent cells 
on day 4 of the culture, adherent rat bone marrow 
stromal cells enriched for MSCs (rMSCs) were cul-
tured to reach 80% confluence before being passaged.
 
Figure S1. (Scheme 1) A surface modification scheme for PEI coated α-(NaYbF4:0.5% Tm3+)@CaF2 UCNPs. 




Cytotoxicity of PEI-UCNPs 
Passage 1 rMSCs were seeded onto 96-well tissue 
culture plates (15,625/cm2 or 5,000/well) and cul-
tured for 24-h prior to the addition of PEI-UCNPs (0, 
20, 50 and 100 µg/mL). Following 4 h or 24 h of in-
cubation with PEI-UCNPs, the cells were washed 3 
times with PBS to remove un-internalized PEI-UCNPs 
and fresh expansion media was added. Cytotoxicity of 
4 h or 24 h treatment with PEI-UCNPs was quantified 
by MTT assay (Roche) 24 h after the initial UCNP 
treatment. The effect of the 24 h UCNP exposure on 
rMSC proliferation was further examined by MTT 48 
h after the removal of un-internalized UCNPs. Three 
replicates were used for each experimental condition. 
Absorbance of the MTT product was read on a Mul-
tiskan FC microplate photometer (Thermo Scientific) 
at 570 nm with a 690nm background correction. 
Imaging of UCNP-labeled rMSCs 
Passage 1 rMSCS were seeded onto glass-bottom 
confocal dishes (MatTek Corp., 12,500/cm2) and cul-
tured for 24 h prior to the addition of PEI-UCNPs (0, 
50 or 100 µg/mL final concentration in media). The 
rMSCs were exposed to the particles for 4 or 24 h be-
fore the un-internalized PEI-UCNPs were removed by 
washing the cells 3 times with PBS. The cells were 
fixed by 3.7 v/v% methanol-free formaldehyde in PBS 
for 10 min and washed 3 times in PBS. Fixed cells 
were permeabilized with Triton X-100 (0.1% in PBS) 
for 5 min, washed with PBS, and then incubated in 
PBS containing 1% BSA for 30 min. Actin was stained 
with 2 units of Alexa Fluor 488-phalloidin (Invitro-
gen) in PBS containing 1% BSA for 20 min. Cell nuclei 
were stained with 300 nM of DAPI (Invitrogen) for 5 
min. Cytoskeletal actin, UCNP uptake, and cell nuclei 
were visualized under a 2-photon microscope (Zeiss 
LSM 7 MP with W Plan-Apochromatic 20X objective) 
with 870-nm excitation for Alexa Fluor 488 phalloidin, 
980-nm excitation for the UCNPs, and 690-nm excita-
tion for DAPI, respectively. 
PEI-UCNP exocytosis from rMSCs 
A transwell system was used to study whether 
the internalized PEI-UCNPs were released from the 
rMSCs. The PEI-UCNP labeled rMSCs (4-h incubation 
with 100 µg/mL particles) were cultured on the 
transwell insert (the upper compartment; 3.0µm pore 
size, polyester membrane). Unlabeled rMSCs were 
cultured in the underlying plate well (the lower 
compartment). The same cell seeding density of 
10,000 rMSCs/cm2 were applied for both top and 
bottom compartments. The labeled and unlabeled 
cells were co-cultured for up to 14 days prior to fixa-
tion, DAPI staining, and imaging as described above. 
To confirm that PEI-UCNPs can pass through the 
transwell membrane, PEI-UCNPs (100 µg/mL) were 
added to a cell-free control upper compartment and 
the rMSCs on the bottom compartment were imaged 
after 24 h. 
Induced differentiations of PEI-UCNP labeled 
rMSCs 
Passage 1 rMSCs (10,500 cells/cm2) were seeded 
onto a 12-well plate and cultured until they reached 
70% confluence. rMSCs were labeled by 4-h incuba-
tion with PEI-UCNPs (100 µg/mL) followed by 3 
washes with PBS. Osteogenic differentiation was in-
duced by supplementing the expansion media with 
10-nM dexamethasone, 20-mM ß-glycerol phosphate, 
and 50-µM L-ascorbic acid 2-phosphate. Adipogenic 
differentiation was induced by supplementing the 
expansion media with 0.5-µM dexamethasone, 0.5-µM 
isobutylmethylxanthine, and 50-µM indomethacin. 
The rMSCs were differentiated for 14 days, with 
changes of differentiation media twice a week, and 
fixed. Osteogenic differentiation was visualized by 
Alizarin Red S staining for mineral deposition. Adi-
pogenic differentiation was visualized by staining 
lipid deposits with Oil Red O. MSCs without UCNP 
labels were cultured, induced to differentiate, and 
stained in the same manner. Staining specificity was 
validated by negative Alizarin Red S staining of cells 
following adipogenic induction and negative Oil Red 
O staining of cells following osteogenic induction. 
Results 
Synthesis and characterization of PEI-UCNPs 
PEI was coupled to the surface of the UCNPs by 
covalent conjugation with the PAA. The nanoparticles 
formed a clear, aggregate free, solution in the PBS 
buffer. The PEI coating preserved the upconversion 
emissions in regard to both visible and near infrared 
regions (Figure 1A). When excited with a 980nm NIR 
laser diode, we observed strong upconversion lumi-
nescence emitted from the nanoparticles in the PBS 
buffer with the naked eye (Figure 1B). TEM imaging 
showed that the PEI-UCNPs are monodispersed in 
size (Figure 1C). In contrast to the electrostatic LbL 
self-assembly approach, we found that covalently 
bound PEI resulted in significantly enhanced stability 
of the PEI-UCNPs. Dynamic light scattering meas-
urement showed that the hydrodynamic nanoparticle 
size of this covalently bonded PEI-UCNP was almost 
identical before and after 24-h incubation in PBS (~ 
91nm), while the size of LbL self-assembled 
PEI-UCNPs increased from ~100nm to ~1um in 5 
hours (Figure 2A). The FT-IR measurements sug-
gested the successful PEI conjugation due to the ap-
pearance of N-H bending peaks. (Figure 2B) Zeta po-




tential measurement of the PEI-UCNPs further con-
firmed the presence of a PEI surface coating with a 
positive potential of approximately +17.8 mV(i.e., in 
comparison with -31 mV of PAA-UCNPs), which 
would be suitable for binding with negatively 
charged cell surfaces.  
 
Figure 1. (A) The upconversion pho-
toluminescence spectrum under laser 
excitation at 980 nm. (B) A photograph 
of PEI-UCNPs when excited by a NIR 
laser at 980 nm. (C) A TEM image of the 
NaYF4:Yb3+,Tm3+/CaF2 nanoparticles 
coated with 25kD PEI. (inset: High 
resolution TEM) (D) X-ray diffraction 
(XRD) patterns of α-NaYbF4:Tm core 



























Figure 2. (A) The hydrodynamic (HD) size distributions of cova-
lently conjugated and LbL self assembled PEI-UCNPs. (B) Plot of 
FT-IR of PAA-UCNPs and PEI-UCNPs. 
  




PEI-UCNP cellular uptake and cytotoxicity  
In order to determine the optimal time and na-
noparticle concentration for stem cell labeling, rMSCs 
were treated with different concentrations of 
PEI-UCNPs (0, 20, 50, or 100 µg/ml) for 4 h and 24 h. 
After incubation, the cells were washed and imaged 
using a 2-photon microscope. The upconversion lu-
minescence was observed in nearly all of the rMSCs, 
demonstrating that the stem cells were successfully 
labeled with the PEI-UCNPs. The level of PEI-UCNP 
uptake in individual cells was proportional to the 
nanoparticle treatment concentration and exposure 
time (Figure 3A). Co-staining for cytoskeletal actin 
and nuclei further validated the localization of -
PEI-UCNP signal within the cytoplasm of rMSCs 
(Figure 3B).  
We next examined the cytotoxicity of the nano-
particle at the aforementioned concentrations and 
time points. The MTT assay showed that nearly 95% 
of rMSCs were viable following a 4 h nanoparticle 
exposure at concentrations up to 100 µg/mL. There 
was no significant difference in cell viability between 
the PEI-UCNP labeled groups and unlabeled control 
(p > 0.05). When the exposure time was increased to 
24 h, the cell viability significantly decreased com-
pared to the unlabeled control at each concentration 
examined, with a 63% reduction at the treatment 
concentration of 100 µg/mL (Figure 3C). There was no 
significant difference in toxicity between 50 µg/ml 
and 100 µg/mL doses at this exposure time. To inves-
tigate the impact of PEI-UCNP labeling on the prolif-
eration capability of rMSCs, rMSCs were incubated 
with PEI-UCNPs at various concentrations for 24 h. 
After removal of un-internalized UCNPs, the cells 
were cultured for another 48 h before being subjected 
to MTT assay. The short-term proliferation of rMSCs 
was minimally impacted by the PEI-UCNP labeling. 
All groups exhibited significant increases in the 
number of viable cells, with 1.84-fold increase in via-
ble cells for rMSCs treated with 100 µg/mL of 
PEI-UCNPs after 48 h culture as compared to 
1.79-fold increase for unlabeled rMSCs (Figure 3D). 
 
Figure 3. The uptake efficiency of PEI-UCNPs by rMSCs and the viability and proliferation of labeled rMSCs. (A) Two-photon microscopy 
images of rMSCs following 4-h and 24-h incubation with various concentrations of PEI-UCNPs. Scale bar = 50 µm (B) Co-localization of 
UCNP signal with rMSC actin and nuclei following incubation with 50 µg/mL UCNPs for 24 h. Scale bar = 50 µm (C) rMSC viability 
following 4 h and 24 h incubation with various concentrations of PEI-UCNPs. Percent viability is calculated relative to the MTT absorbance 
of unlabeled rMSCs. (D) The impact of PEI-UCNP labeling on rMSC proliferation as determined by MTT assay. Significance of statistical 
comparisons were determined by one-way ANOVA with Tukey post-hoc. All pairwise comparisons are significant (p < 0.05) unless 
denoted as n.s. (p > 0.05, not significant). 




Exocytosis of PEI-UCNPs from labeled rMSCs 
One potential challenge for in vivo tracking of 
UCNP-labeled stem cells is the possibility that the 
uptaken nanoparticles could be exocytosed overtime, 
leading to the unintended labeling of other sur-
rounding cells. We investigated this issue using a 
transwell culture system[29] where rMSCs labeled 
with PEI-UCNPs (100 µg/mL, 4h) were cultured on 
the porous membrane in the upper compartment 
while the unlabeled rMSCs were cultured in the lower 
compartment (Figure 4A). PEI-UCNPs added to a 
cell-free upper compartment were able to quickly pass 
through the membrane and cause the labeling of 
rMSCs seeded in the lower compartment in 1 day 
(Figure 4B, control). The labeled and unlabeled cells 
were co-cultured for 14 days and the cells in the bot-
tom compartment remained free of any PEI-UCNP 
signal throughout this culture period, supporting that 
there was no particles excytosed from the labeled cells 
in the upper compartment (Figure 4D).  
Differentiation of PEI-UCNP labeled rMSCs 
 The effect of PEI-UCNP labeling on the osteo-
genic and adipogenic differentiations of rMSCs were 
assessed. Passage 1 rMSCs labeled with PEI-UCNPs 
(100 µg/mL, 4 h) were cultured in osteogenic or adi-
pogenic media for 14 days and their differentiation 
potency was compared with that of unlabeled MSCs. 
Light microscopy shows that the PEI-UCNP labeled 
rMSCs were able to undergo osteogeneic and adipo-
genic differentiation as supported by the positive 
Alizarin Red S (Figure 5A) and Oil Red O (Figure 5B) 
staining, respectively. The intensity of Alizarin red S 
staining, however, was reduced for the PEI-UCNP 
labeled rMSCs compared to the unlabeled control 
(Figure 5A).  
Discussion 
 The ability to label and track stem cells has far 
reaching applications in tissue engineering and re-
generative medicine, where the fate of implanted stem 
cells remains unclear. Stem cell labeling with NIR 
probes has the potential to allow for the in vivo study 
of stem cell fate with greater tissue penetration depth 
and spatial resolution than conventional cell labeling 
methods. Herein, we report the application of a re-
cently developed UCNP with NIR-excitation and 
NIR-emission to the labeling of rMSCs. 
 We compared two approaches of modifying the 
surface of the UCNPs with PEI, facilitating 
non-specific cellular uptake. In one approach, we 
used an LbL method that deposits PEI by electrostatic 
interactions around the nanoparticle surface. In a 
second approach, we covalently coupled the PEI to 
the UCNP surface through a PAA intermediate. The 
presence of a PEI coating was confirmed by zeta po-
tential measurements that indicated a positive charge 
on the particle surface. We found that the covalently 
linked PEI resulted in increased particle stability, with 
no increase in hydrodynamic size over the course of a 
24 h incubation in PBS. In contrast, the LbL assembled 
PEI resulted in rapid particle aggregation in PBS. Due 
to their increased stability, we chose the UCNPs with 
the covalently coupled PEI coating (PEI-UCNPs) for 
further cell-based analysis. 
 
Figure 4. Exocytosis of PEI-UCNPs by labeled rMSCs. (A) Schematic of a control transwell setup containing PEI-UCNPs on the top well 
membrane and rMSCs on the bottom well, and the two-photon imaging of the bottom dish rMSCs. (B) Schematic of a transwell co-culture 
setup containing PEI-UCNP labeled rMSCs on top well membrane and unlabeled rMSCs on the bottom dish, and the two-photon imaging 
of the bottom dish rMSCs over a 14 day period. Cell nuclei were stained with DAPI. Scale bar = 50 µm. 





Figure 5. Osteogenic and adipogenic differentiation of PEI-UCNP labeled rMSCs. (A) Alizarin red S staining of unlabeled rMSCs after 
14-day culture in adipogenic (negative staining control) and osteogenic media (positive control), and labeled rMSCs after 14-day culture in 
osteogenic media. Scale bar = 100 µm. (B) Oil red O staining of unlabeled rMSCs after 14-day culture in osteogenic (negative staining 
control) and adipogenic media (positive control), and labeled rMSCs after 14-day culture in adipogenic media. Scale bar = 100 µm. 
 
 We used rMSCs as a model to determine the ef-
ficacy of PEI-UCNPs for stem cell labeling. MSCs are a 
multipotent cell that can differentiate into osteoblasts, 
chondrocytes, myocytes and adipocytes. They have 
been studied widely for musculoskeletal tissue engi-
neering and have been used clinically.[30-32] Track-
ing labeled MSCs in vivo is important for the valida-
tion and development of MSC-based therapeutic 
strategies. We show that the PEI-UCNP concentration 
and incubation-time can be optimized to achieve effi-
cient rMSCs labeling with negligible cytotoxicity. 
Specifically, we showed that a 4 h incubation with 100 
µg/mL PEI-UCNPs effectively labeled rMSCs while 
maintaining ~95% cell viability. Although a longer 
exposure of 24 h did lead to increased cytotoxicity in a 
dose dependent manner, the cytotoxicity did appear 
to level off beyond a particle concentration of 50 
µg/mL. Further, UCNP signals were localized to the 
rMSC cytoplasm and did not negatively impact the 
short-term (48 h) proliferation of MSCs.  
Transwell coculture experiments showed that 
PEI-UCNP internalized in the rMSCs did not leak out 
via exocytosis during a 14-day period to cause unin-
tended labeling of surrounding cells. This supports 
the feasibility of in vivo cell tracking over a couple of 
weeks without causing non-specific secondary label-
ing of other cells. Finally, we showed that PEI-UCNP 
labeled rMSCs were able to differentiate along the 
osteogenic and adipogenic lineages upon in vitro in-
duction, suggesting that the PEI-UCNP labeling did 
not abolish these key functions of MSCs. Although the 
PEI-UCNP labeled rMSCs exhibited less potent oste-
ogenic differentiation than the unlabeled control, the 
potency of adipogenic differentiation was largely un-
affected by PEI-UCNP labeling. It remains to be seen 
whether other lineage commitments and in vivo dif-
ferentiation of MSCs is affected by the PEI-UCNP 
labeling. Finally, the observed impact on the osteo-
genic differentiation potency of PEI-UCNP labeled 
rMSCs may be further minimized by exploring even 
more cytocompatible surface coating strategies.  
Conclusions 
The NIR-excitation and NIR-emission of 
α-NaYF4:Yb3+,Tm3+/CaF2 UCNPs allows for increased 
tissue penetration depth, facilitating in vivo imaging. 
We report the development of core/shell 
α-NaYF4:Yb3+,Tm3+/CaF2 UCNPs with a covalently 




coupled PEI coating (PEI-UCNPs) and their validation 
for stem cell labeling applications. We show that the 
covalently coupled PEI coating results in greater par-
ticle stability in PBS than UCNPs coated with PEI us-
ing a layer-by-layer approach. The PEI-UCNPs show 
reasonable cytocompatibility at a concentration and 
exposure time adequate for efficient labeling of 
rMSCs. The cell viability remained above 95% after a 4 
h PEI-UCNP exposure at 100 µg/mL. Further, the 
PEI-UCNP labeling did not impair short-term cell 
proliferation. Exocytosis of internalized PEI-UCNP 
from labeled cells was not observed during a 14-day 
culture period. Finally, PEI-UCNPs labeled rMSCs 
were able to undergo osteogenic and adipogenic dif-
ferentiations upon in vitro induction, although the 
potency of the former was reduced compared to un-
labeled control. Taken together, PEI-UCNPs have 
promising applications in cell labeling and in vivo 
tracking. 
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